Subscribe to Newsletter
Diagnostics Oncology, Genetics and epigenetics

Rapid molecular profiling is essential to optimize patient outcomes - Real-world data analysis

sponsored by Thermo Fisher Scientific

Register here

November 30, 2023 - 5pm CET

In their retrospective study Integra Connect investigated how this behavior affects outcomes. In this webinar Jeffrey A. Scott, MD, will present the methods, collected data and results, leading to the following conclusion: For patients harboring AODs in advanced NSCLC, initial treatment before receipt of genomic test results yields significantly inferior outcomes and should be avoided.

Register here

Receive content, products, events as well as relevant industry updates from The Pathologist and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine